NM_001106.4:c.1075-5C>T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_001106.4(ACVR2B):​c.1075-5C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00822 in 1,613,656 control chromosomes in the GnomAD database, including 69 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0064 ( 5 hom., cov: 29)
Exomes 𝑓: 0.0084 ( 64 hom. )

Consequence

ACVR2B
NM_001106.4 splice_region, intron

Scores

2
Splicing: ADA: 0.00002324
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.771

Publications

1 publications found
Variant links:
Genes affected
ACVR2B (HGNC:174): (activin A receptor type 2B) Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I (I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. Type II receptors are considered to be constitutively active kinases. This gene encodes activin A type IIB receptor, which displays a 3- to 4-fold higher affinity for the ligand than activin A type II receptor. [provided by RefSeq, Jul 2008]
ACVR2B Gene-Disease associations (from GenCC):
  • heterotaxy, visceral, 4, autosomal
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 3-38482193-C-T is Benign according to our data. Variant chr3-38482193-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 136290.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 976 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001106.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACVR2B
NM_001106.4
MANE Select
c.1075-5C>T
splice_region intron
N/ANP_001097.2Q13705-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACVR2B
ENST00000352511.5
TSL:1 MANE Select
c.1075-5C>T
splice_region intron
N/AENSP00000340361.3Q13705-1
ACVR2B
ENST00000461232.1
TSL:1
n.4864-5C>T
splice_region intron
N/A
ACVR2B
ENST00000922132.1
c.1051-5C>T
splice_region intron
N/AENSP00000592191.1

Frequencies

GnomAD3 genomes
AF:
0.00643
AC:
976
AN:
151678
Hom.:
5
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.00187
Gnomad AMI
AF:
0.00220
Gnomad AMR
AF:
0.00840
Gnomad ASJ
AF:
0.00605
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00105
Gnomad FIN
AF:
0.00133
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0103
Gnomad OTH
AF:
0.0115
GnomAD2 exomes
AF:
0.00670
AC:
1685
AN:
251410
AF XY:
0.00668
show subpopulations
Gnomad AFR exome
AF:
0.00185
Gnomad AMR exome
AF:
0.00749
Gnomad ASJ exome
AF:
0.00863
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00148
Gnomad NFE exome
AF:
0.0105
Gnomad OTH exome
AF:
0.0103
GnomAD4 exome
AF:
0.00840
AC:
12284
AN:
1461860
Hom.:
64
Cov.:
32
AF XY:
0.00842
AC XY:
6121
AN XY:
727230
show subpopulations
African (AFR)
AF:
0.00206
AC:
69
AN:
33480
American (AMR)
AF:
0.00809
AC:
362
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00784
AC:
205
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00143
AC:
123
AN:
86256
European-Finnish (FIN)
AF:
0.00172
AC:
92
AN:
53416
Middle Eastern (MID)
AF:
0.0114
AC:
66
AN:
5768
European-Non Finnish (NFE)
AF:
0.00980
AC:
10895
AN:
1111994
Other (OTH)
AF:
0.00782
AC:
472
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
727
1454
2181
2908
3635
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
390
780
1170
1560
1950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00643
AC:
976
AN:
151796
Hom.:
5
Cov.:
29
AF XY:
0.00603
AC XY:
447
AN XY:
74182
show subpopulations
African (AFR)
AF:
0.00186
AC:
77
AN:
41342
American (AMR)
AF:
0.00839
AC:
128
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.00605
AC:
21
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5168
South Asian (SAS)
AF:
0.00105
AC:
5
AN:
4774
European-Finnish (FIN)
AF:
0.00133
AC:
14
AN:
10544
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.0103
AC:
698
AN:
67936
Other (OTH)
AF:
0.0114
AC:
24
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
47
94
142
189
236
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00799
Hom.:
2
Bravo
AF:
0.00685
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.0103
EpiControl
AF:
0.0122

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
Heterotaxy, visceral, 4, autosomal (4)
-
-
3
not provided (3)
-
-
3
not specified (3)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
0.28
DANN
Benign
0.69
PhyloP100
-0.77
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000023
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115155428; hg19: chr3-38523684; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.